SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $23.00.
Several analysts have weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and set a $19.00 target price on shares of SI-BONE in a research note on Wednesday, November 20th. Truist Financial lifted their target price on SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th.
Read Our Latest Research Report on SIBN
Insider Transactions at SI-BONE
Institutional Investors Weigh In On SI-BONE
Institutional investors and hedge funds have recently modified their holdings of the stock. Millrace Asset Group Inc. acquired a new stake in shares of SI-BONE during the third quarter worth $1,056,000. Champlain Investment Partners LLC raised its position in shares of SI-BONE by 14.7% during the third quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company’s stock worth $39,145,000 after purchasing an additional 358,821 shares during the period. Impax Asset Management Group plc raised its position in shares of SI-BONE by 41.3% during the third quarter. Impax Asset Management Group plc now owns 758,521 shares of the company’s stock worth $10,604,000 after purchasing an additional 221,604 shares during the period. American Century Companies Inc. raised its position in shares of SI-BONE by 22.8% during the second quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock worth $25,685,000 after purchasing an additional 368,637 shares during the period. Finally, Divisadero Street Capital Management LP purchased a new position in shares of SI-BONE during the second quarter valued at $1,552,000. 98.11% of the stock is owned by institutional investors and hedge funds.
SI-BONE Stock Up 0.5 %
Shares of SI-BONE stock opened at $13.84 on Wednesday. The business’s fifty day moving average price is $13.40 and its two-hundred day moving average price is $14.10. The company has a debt-to-equity ratio of 0.22, a current ratio of 8.25 and a quick ratio of 7.22. The company has a market capitalization of $580.42 million, a P/E ratio of -15.04 and a beta of 1.20. SI-BONE has a 1-year low of $11.70 and a 1-year high of $21.70.
About SI-BONE
SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.
See Also
- Five stocks we like better than SI-BONE
- High Dividend REITs: Are They an Ideal Way to Diversify?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Trading Stocks: RSI and Why it’s Useful
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- How to Invest in the Best Canadian Stocks
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for SI-BONE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-BONE and related companies with MarketBeat.com's FREE daily email newsletter.